American Healthcare REIT (AHR) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

American Healthcare REIT Inc (AHR) Prix de l'Action, Cotation, Actualités et Historique

AHRNYSE

Trade with Public

Trade with Public

$52.42

-0.11-0.21%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Dividendes Comparer Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

$52.42

Volume / Moy.

- / 2.90M

Fourchette Journalière

- - -

Plage 52 Sem.

40.30 - 58.70

Capitalisation Boursière

$11.45B

Ratio P/E

77.09

Rendement des Dividendes

1.91%

Échange

NYSE

RSI

52

Intérêt à Découvert

16.57%

Jours pour Couvrir

8.56

Actualités Récentes de American Healthcare REIT, Inc.

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).

Avi Kapoor

How AHR’s $873M Kensington Deal Could Shift Its Dividend Payout Ratio

The Print American Healthcare REIT, Inc. (NYSE:AHR) has closed six of the eight senior housing communities in its $873 million Kensington Senior Living portfolio. The first closings total approximately $572 million

Jeong-Mo Goo

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.

Avi Kapoor

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.

Avi Kapoor

This IBM Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Top Wall Street analysts changed outlook on top names. Piper Sandler upgraded SNPS, JP Morgan upgraded IBM,. See analyst ratings.

Avi Kapoor

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

362.04M

Flux de Trésorerie d'Investissement (TTM)

-1.36B

Flux de Trésorerie de Financement (TTM)

1.02B

Flux de Trésorerie Libre (TTM)

195.55M

Dépenses en Capital (TTM)

-166.49M

Variation Nette de la Trésorerie (TTM)

21.72M

Tendances et prévisions des analystes

3

juil.

5

août

0

0

0

0

sept.

3

oct.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

4.1

Acheter

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$12.84B

Ratio P/E (TTM)

77.09

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

3.82

Ratio P/B (TTM)

3.09

Rendement des Bénéfices % (TTM)

1.30%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

28.14

Prix / EBITDA (TTM)

20.97

Prix / Flux de Trésorerie Libre (TTM)

48.93

Valeur Comptable / Action

$16.95

Dette Entreprise

Dette Totale

$1.44B

Dette à Long Terme

$892.68M

Émission de Dette à Long Terme (TTM)

$116.00M

Remboursement de la Dette à Long Terme (TTM)

-$231.32M

Trésorerie Totale

$156.90M

Dette sur Capitaux Propres

0.42

Émission de Dette (TTM)

-$115.32M

Remboursement de la Dette (TTM)

-$231.32M